Cargando…
Immunobiology of Steroid-Unresponsive Severe Asthma
Asthma is a heterogeneous respiratory disease characterized by airflow obstruction, bronchial hyperresponsiveness and airway inflammation. Approximately 10% of asthma patients suffer from uncontrolled severe asthma (SA). A major difference between patients with SA from those with mild-to-moderate as...
Autores principales: | Marshall, Courtney Lynn, Hasani, Kosovare, Mookherjee, Neeloffer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974815/ https://www.ncbi.nlm.nih.gov/pubmed/35387021 http://dx.doi.org/10.3389/falgy.2021.718267 |
Ejemplares similares
-
Inflammatory Remission in T2 Severe Asthma
por: Rial, Manuel J., et al.
Publicado: (2022) -
COVID-19, Eosinophils, and Biologicals for Severe Asthma
por: Lombardi, Carlo, et al.
Publicado: (2022) -
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023) -
Performance of Three Asthma Predictive Tools in a Cohort of Infants Hospitalized With Severe Bronchiolitis
por: C. Fabiano Filho, Ronaldo, et al.
Publicado: (2021) -
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2022)